Melbourne Securities Corporation [Horizon 3 Biotech] is a major AVE shareholder and options holder and pet project of Matt McNamara [AVE director].It would be a bad look for that investment fund and its subsequent growth performance if AVE went under. I am just guessing but it may be that this group is still a source of possible future funding if cash/timing is the only problem.
Kens
Ann: December 2022 Quarterly Activities Report & Appendix 4C, page-17
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $580 | 200K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 29443702 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 52585197 | 27 |
View Market Depth
| Last trade - 13.20pm 18/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |